CAPE news

DoubleLine Shiller CAPE U.S. Equities · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
9.2% of CAPE
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
7.0% of CAPE
CNBC · 28 Oct 2026, 22:26 UTC
Jim Cramer says these tech giants can weather market turbulence
5.5% of CAPE
24/7 Wall St. · 28 Oct 2026, 18:54 UTC
Alphabet Is Only Up 3% This Year: Will Today's Earnings Report Make or Break GOOGL Stock?
5.5% of CAPE
Where to buy CAPE
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
5.8% of CAPE
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
5.9% of CAPE
Where to buy CAPE
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
CNBC · 28 Oct 2026, 16:19 UTC
Looking for yield? This could be one of the best times in recent market history to buy corporate bonds
5.5% of CAPE
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
5.8% of CAPE
CNBC · 28 Oct 2026, 13:00 UTC
The 'Magnificent Seven' is no more. Time to pick winners and losers as group's correlation breaks down
5.5% of CAPE
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
4.4% of CAPE
Yahoo! Finance · 28 Oct 2026, 07:46 UTC
Zacks Investment Ideas feature highlights: Meta, Tesla, Microsoft and Alphabet
5.5% of CAPE
The Wall Street Journal · 29 Oct 2026, 01:00 UTC
The Beleaguered Chip Sellers Getting Their Revenge on Apple
3.2% of CAPE
The Wall Street Journal · 29 Oct 2026, 01:00 UTC
Tech Giants Ramp Up Resistance to ICE in Bid to Avoid Democratic Scrutiny
3.2% of CAPE
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
4.4% of CAPE
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
4.4% of CAPE
BBC · 28 Oct 2026, 23:10 UTC
BBC Audio | Business Daily | Power players: Can Meta reinvent itself for the AI age?
3.2% of CAPE
TheStreet · 28 Oct 2026, 23:03 UTC
Nvidia's $3 billion Meta bet reveals a 30-fold shift
3.2% of CAPE
Investing.com · 28 Oct 2026, 22:45 UTC
Meta director Peggy Alford sells $249,600 in stock By Investing.com
3.2% of CAPE
Investing.com · 28 Oct 2026, 22:45 UTC
Meta Platforms COO Javier Olivan sells $1M in company stock By Investing.com
3.2% of CAPE
Mashable · 28 Oct 2026, 21:33 UTC
What is Waddle World? Meta's new virtual pet journal app
3.2% of CAPE